Cardiovascular Department, Chang Gung Memorial Hospital, Linkou, Taiwan.
College of Medicine, Chang Gung University, Taoyuan, Taiwan.
JAMA Cardiol. 2017 Aug 1;2(8):863-870. doi: 10.1001/jamacardio.2017.1855.
The heritability of atrial fibrillation (AF), the contribution of genetic and environmental factors, and the association of a family history of AF with prognosis are unclear.
To measure genetic and environmental factors in the familial aggregation of AF and to estimate the association of a family history of AF with major adverse cardiovascular events (MACE).
DESIGN, SETTING, AND PARTICIPANTS: In this Taiwanese nationwide population-based study among more than 23 million people, a custom data set was obtained using the data of all patients having a diagnosis of AF recorded between January 1996 and December 2013 in the Taiwan National Health Insurance Research Database. The study population comprised all 23 422 955 individuals registered with the database in 2013, of whom 177 770 had a diagnosis of AF and were included in the heritability estimation. From the latter, a subgroup of patients having newly diagnosed AF with a first-degree relative affected by AF between 2000 and 2010 were selected and matched 1:4 to controls without a family history for estimating MACE-free survival. The dates of analysis were January 2010 to December 2013.
The prevalence and relative risk of AF in relatives of patients with AF, as well as the relative contributions of heritability and shared and nonshared environmental factors to AF susceptibility. Also measured was MACE-free survival after AF was diagnosed.
In total, 1510 patients (204 [13.5%] female; mean [SD] age, 57.9 [9.2] years) had newly diagnosed AF with a first-degree relative affected by AF. Individuals with a first-degree relative affected by AF had a relative risk of 1.92 (95% CI, 1.84-1.99) for AF. The accountability for the phenotypic variance of AF was 19.9% for genetic factors (heritability), 3.5% for shared environmental factors, and 76.6% for nonshared environmental factors. After matching for age, sex, hypertension, type 2 diabetes, previous stroke, and anticoagulation, incident AF patients with vs without an affected first-degree relative had similar MACE-free survival.
Genetic and environmental factors were associated with AF, with nonshared environmental factors accounting for three-fourths of the phenotypic variance in Taiwan. Patients having AF with a first-degree relative affected by AF did not have more MACE. Therefore, family history may not be particularly informative in the diagnosis or management of AF.
心房颤动(AF)的遗传率、遗传和环境因素的贡献,以及 AF 家族史与预后的关系尚不清楚。
测量 AF 家族聚集的遗传和环境因素,并评估 AF 家族史与主要不良心血管事件(MACE)的关系。
设计、地点和参与者:在这项针对超过 2300 万人的台湾全国范围内基于人群的研究中,使用了 1996 年 1 月至 2013 年 12 月期间在台湾全民健康保险研究数据库中记录的所有 AF 诊断患者的数据,获得了一个定制数据集。该研究人群包括 2013 年数据库中登记的 23422955 名患者,其中 177770 名患者患有 AF,被纳入遗传率估计。从后者中,选择了一组在 2000 年至 2010 年期间有一级亲属患有 AF 的新诊断为 AF 的患者,并按 1:4 与无家族史的对照组相匹配,以估计 AF 诊断后的无 MACE 生存率。分析日期为 2010 年 1 月至 2013 年 12 月。
AF 患者一级亲属中 AF 的患病率和相对风险,以及遗传和共同及非共同环境因素对 AF 易感性的相对贡献。还测量了 AF 诊断后的无 MACE 生存率。
共有 1510 名患者(204 名女性[13.5%];平均[标准差]年龄 57.9[9.2]岁)新诊断为 AF,一级亲属中有一名患者患有 AF。有一级亲属患 AF 的个体发生 AF 的相对风险为 1.92(95%置信区间,1.84-1.99)。AF 的表型方差的遗传因素(遗传率)占 19.9%,共同环境因素占 3.5%,非共同环境因素占 76.6%。在按年龄、性别、高血压、2 型糖尿病、既往卒中和抗凝治疗进行匹配后,新发 AF 患者中一级亲属有 AF 与无 AF 的患者的无 MACE 生存率相似。
遗传和环境因素与 AF 相关,非共同环境因素占台湾 AF 表型方差的四分之三。有一级亲属患 AF 的 AF 患者的 MACE 发生率无差异。因此,家族史在 AF 的诊断或管理中可能不是特别有用。